BACKGROUND: The objective of this study was to examine the impact of self-expanding stents versus locoregional treatment modalities in the setting of esophageal cancer palliation. METHODS: The present meta-analysis pooled the effects of outcomes of 1,027 patients enrolled in 16 randomized controlled trials. RESULTS: The meta-analysis revealed an advantage to the use of stents compared to locoregional modality treatments with respect to the number of patients requiring reinterventions, although the latter treatment arm had a higher 1-year survival. No difference was observed between the use of the antireflux stents and conventional stents in relieving reflux. Previous chemoradiotherapy had no impact on complications, procedural deaths, and overall patient survival. Differences in outcomes among stents were minimal. CONCLUSIONS: Conventional self-expanding stents and anti-reflux stents are equally effective. Although the risk difference for 1-year survival favoured locoregional palliative treatment modalities, the latter were associated with a higher number of patients requiring reintervention.
BACKGROUND: The objective of this study was to examine the impact of self-expanding stents versus locoregional treatment modalities in the setting of esophageal cancer palliation. METHODS: The present meta-analysis pooled the effects of outcomes of 1,027 patients enrolled in 16 randomized controlled trials. RESULTS: The meta-analysis revealed an advantage to the use of stents compared to locoregional modality treatments with respect to the number of patients requiring reinterventions, although the latter treatment arm had a higher 1-year survival. No difference was observed between the use of the antireflux stents and conventional stents in relieving reflux. Previous chemoradiotherapy had no impact on complications, procedural deaths, and overall patient survival. Differences in outcomes among stents were minimal. CONCLUSIONS: Conventional self-expanding stents and anti-reflux stents are equally effective. Although the risk difference for 1-year survival favoured locoregional palliative treatment modalities, the latter were associated with a higher number of patients requiring reintervention.
Authors: C S Shim; I S Jung; Y K Cheon; C B Ryu; S J Hong; J O Kim; J Y Cho; J S Lee; M S Lee; B S Kim Journal: Endoscopy Date: 2005-04 Impact factor: 10.093
Authors: A Königsrainer; B Riedmann; A De Vries; D Ofner; B Spechtenhauser; F Aigner; E Fritsch; R Margreiter Journal: Hepatogastroenterology Date: 2000 May-Jun
Authors: David H Ilson; Manjit Bains; David P Kelsen; Eileen O'Reilly; Martin Karpeh; Daniel Coit; Valerie Rusch; Mithat Gonen; Katie Wilson; Bruce D Minsky Journal: J Clin Oncol Date: 2003-08-01 Impact factor: 44.544
Authors: Massimo Conio; Alessandro Repici; Giorgio Battaglia; Giovanni De Pretis; Luigi Ghezzo; Max Bittinger; Helmut Messmann; Jean-François Demarquay; Sabrina Blanchi; Michele Togni; Rita Conigliaro; Rosangela Filiberti Journal: Am J Gastroenterol Date: 2007-12 Impact factor: 10.864
Authors: Peter S N van Rossum; Nadia Haj Mohammad; Frank P Vleggaar; Richard van Hillegersberg Journal: Nat Rev Gastroenterol Hepatol Date: 2017-12-13 Impact factor: 46.802
Authors: Zachary L Smith; Jason E Gonzaga; George B Haasler; Elizabeth M Gore; Kulwinder S Dua Journal: Dig Dis Sci Date: 2017-04-08 Impact factor: 3.199
Authors: George Sgourakis; Ines Gockel; Constantine Karaliotas; Markus Moehler; Carl Christoph Schimanski; Heinz Schmidberger; Theodor Junginger Journal: BMC Cancer Date: 2012-02-15 Impact factor: 4.430